Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 21, 2006; 12(15): 2466-2468
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2466
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2466
Fulminant hepatic failure resulting from small-cell lung cancer and dramatic response of chemotherapy
Kyoichi Kaira, Atsushi Takise, Rieko Watanabe, Department of Respiratory Medicine, Maebashi Red Cross Hospital 3-21-36, Asahi-cho, Maebashi, Gunma 371-0014, Japan
Kyoichi Kaira, Masatomo Mori, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan
Correspondence to: Kyoichi Kaira, MD, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Showa-machi, Maebashi, Gunma 371-8511, Japan. kkaira1970@yahoo.co.jp
Telephone: +81-27-2208136
Received: November 29, 2005
Revised: January 2, 2006
Accepted: January 14, 2006
Published online: April 21, 2006
Revised: January 2, 2006
Accepted: January 14, 2006
Published online: April 21, 2006
Abstract
Prompt treatment in tumor-associated encephalopathy may prolong survival. We describe a 69-year-old male patient who was presented with fulminant hepatic failure, secondary to small-cell lung carcinoma with rapidly progressing encephalopathy. Both symptoms remitted following chemotherapy, suggesting swift diagnosis and administration of chemotherapy to be effective in treatment of fulminant hepatic failure and encephalopathy.